Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs

IntroductionPulmonary fibrosis is a destructive, progressive disease that dramatically reduces life quality of patients, ultimately leading to death. Therapeutic regimens for pulmonary fibrosis have shown limited benefits, hence justifying the efforts to evaluate the outcome of alternative treatment...

Full description

Bibliographic Details
Main Authors: Rafael F. Guilherme, José Bruno N.F. Silva, Ingrid Waclawiack, Vanderlei S. Fraga-Junior, Thaís O. Nogueira, Cyntia Pecli, Carlla A. Araújo-Silva, Nathalia S. Magalhães, Felipe S. Lemos, Carlos A. Bulant, Pablo J. Blanco, Rafaela Serra, Erik Svensjö, Júlio Scharfstein, João A. Moraes, Claudio Canetti, Claudia F. Benjamim
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.886601/full